Shu Li
Peking University(CN)Kunming Medical University(CN)Peking University Cancer Hospital(CN)The Fifth People's Hospital of Anyang(CN)First Affiliated Hospital of Kunming Medical University(CN)Ministry of Education(ET)Chongqing Medical University(CN)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Sarcoma Diagnosis and Treatment, Systemic Lupus Erythematosus Research, Ferroptosis and cancer prognosis, Autoimmune and Inflammatory Disorders Research
Most-Cited Works
- → Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials(2014)293 cited
- → Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS/HO-1/GPX4 axis(2023)193 cited
- → Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension(1999)165 cited
- → Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)(2016)155 cited
- → NOX4 Regulates ROS Levels Under Normoxic and Hypoxic Conditions, Triggers Proliferation, and Inhibits Apoptosis in Pulmonary Artery Adventitial Fibroblasts(2008)128 cited